TuHURA Biosciences, Inc. (NASDAQ: HURA) ("TuHURA"), a Phase 3 immune-oncology company developing novel technologies to overcome resistance to cancer immunotherapy, today announced that its research on ...
CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with ...
Human astroviruses are a leading viral cause of the stomach bug-think vomiting, diarrhea, and fever. It often impacts young children and older adults, leading to vicious cycles of sickness and ...
TScan Therapeutics is laying off 30% of its workforce as the T-cell receptor (TCR) therapy biotech abandons a phase 1 solid ...
Thomas Jefferson University scientist Raymond Penn spends his days searching for the molecules that could be the key to better asthma treatments. He’s invested decades into this goal, for which stakes ...
New research led by the University of Minnesota Medical School demonstrates that molecules acting as "molecular bumpers" and "molecular glues" can rewire G protein-coupled receptor (GPCR) signaling, ...
Biosensing plays a fundamental role in the latest technology that sheds light on how G protein-coupled receptors are activated by synthetic cannabinoid receptor agonists.
ORLANDO, FLORIDA / ACCESS Newswire / October 30, 2025 / RedChip Companies will host an investor webinar with Connect Biopharma Holdings Limited (Nasdaq:CNTB) (Connect Biopharma, Connect or the Company ...
This article reviews the interplay between histamine and serotonin in upper GI motility and highlights three clinical cases. It provides practical insights into assessment, treatment strategies, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback